Bio Business

» FDA, regulation and cancer

Most Recent

image: Battling the Bulge

Battling the Bulge

By | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.


image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

1 Comment

image: The CAR T-Cell Race

The CAR T-Cell Race

By | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.

1 Comment

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

image: That Loving Feeling

That Loving Feeling

By | July 1, 2014

There are no FDA-approved drugs to treat low sexual desire in women, but not for lack of trying.

1 Comment

image: How Safe Is Your Medicine Cabinet?

How Safe Is Your Medicine Cabinet?

By | May 1, 2013

After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.

1 Comment

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Bioterrorist Battles

Bioterrorist Battles

By | January 1, 2012

A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.


image: Make Mine Rare

Make Mine Rare

By | August 1, 2011

With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.


image: Take Two of These

Take Two of These

By | June 22, 2011

Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.


Popular Now

  1. Antidepressant Exerts Epigenetic Changes
  2. Inside a Lab Mouse’s High-Fat Diet
  3. Remote Mind Control
  4. Image of the Day: Mother’s Love
Life Technologies